BD Recognized by DiversityInc in Annual Ranking of Top US Companies for Diversity
Named a “Noteworthy Company” for Third Straight Year


FRANKLIN LAKES, N.J. (May 13, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named a “Noteworthy Company” for the third straight year in DiversityInc’s annual ranking of the top U.S. companies for diversity.

Since 2001, the DiversityInc survey has been the most comprehensive, empirically data-driven diversity and inclusion analysis based on organization-submitted information from the largest U.S. employers. The assessment collects data across six key areas: leadership accountability, human capital diversity metrics, talent programs, workplace practices, supplier diversity and philanthropy.

“An inclusive environment and diverse workforce produces better outcomes for customers and patients, and is core to our purpose of advancing the world of health™ for all,” said Nicole Thompson, vice president of HR – Inclusion, Diversity, Equity & Engagement at BD. “We will continue to accelerate our progress to further empower our associates to thrive personally and professionally, and make a difference in our communities.”

This year BD was also recognized by Forbes as one of the top employers in the U.S. for diversity, included in the 2022 Bloomberg Gender-Equality Index, and named a Best Place to Work for LGBTQ+ Equality by The Human Rights Campaign Foundation after receiving a perfect score (100%) on the organization's Corporate Equality Index.

These recognitions demonstrate the company’s ongoing progress in advancing its environmental, social and governance (ESG) strategy, and efforts to achieve its 2030+ goals for promoting a healthy workforce and communities. These goals encompass maintaining a healthy and thriving workforce that cultivates the company's culture of inclusion, safety, well-being, and also contributes to community and company health.

To learn more about the inclusion, diversity and equity systems, processes and tools that drive action and accountability at BD, read the 2021 Global ID&E Report.


About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at and Twitter @BDandCo.


Media:                                                                                 Investors:

Troy Kirkpatrick                                                                   Francesca DeMartino
VP, Public Relations                                                            SVP, Head of Investor Relations
858.617.2361                                                                      201.847.5743